Oxygen Biotherape receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tenax Therapeutics Inc (TENX)
Tenax Therapeutics Inc stock price live, this page displays NASDAQ TENX stock exchange data. View the TENX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tenax Therapeutics Inc real time stock price chart below.
What Is the Tenax Therapeutics Inc Stock Price Today?
The Tenax Therapeutics Inc stock price today is 1.7350.
What Is the Stock Symbol for Tenax Therapeutics Inc?
The stock ticker symbol for Tenax Therapeutics Inc is TENX.
Is TENX the Same as $TENX?
$TENX is a common way to refer to the Tenax Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Tenax Therapeutics Inc Trade On?
Tenax Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenax Therapeutics Inc a Good Stock to Buy?
Determining whether Tenax Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Tenax Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TENX quote. (ISIN: US88032L6056)
What Is the Tenax Therapeutics Inc Stock Price Today?
The Tenax Therapeutics Inc stock price today is 1.7350.
What Is the Stock Symbol for Tenax Therapeutics Inc?
The stock ticker symbol for Tenax Therapeutics Inc is TENX.
Is TENX the Same as $TENX?
$TENX is a common way to refer to the Tenax Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Tenax Therapeutics Inc Trade On?
Tenax Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Tenax Therapeutics Inc a Good Stock to Buy?
Determining whether Tenax Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Tenax Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TENX quote. (ISIN: US88032L6056)
1.7350
-0.0450(-2.53%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7300
1.8400
52 wk Range
1.3100
19.4000
TENX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.73001.8400
52 wk Range
1.310019.4000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TENX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
11.7000
Upside
+574.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Oxygen Biotherape receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Oxygen Biotherape receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Oxygen Biotherape receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
7 Buy
3 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 11.7000
(+574.35% Upside)
Earnings
Latest Release
Jul 31, 2026
EPS / Forecast
-0.35 / -0.38
Revenue / Forecast
-- / --
Compare TENX to Peers and Sector
Metrics to compare | TENX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTENXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −1.9x | −0.3x | |
PEG Ratio | 0.03 | −0.03 | 0.00 | |
Price / Book | 0.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 6.6x | 3.1x | |
Upside (Analyst Target) | 180.9% | 121.0% | 47.6% | |
Fair Value Upside | Unlock | 8.6% | 5.6% | Unlock |
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tenax Therapeutics (TENX) Stock Price Today?
The Tenax Therapeutics stock price today is 1.7350 USD.
What Stock Exchange Does Tenax Therapeutics Trade On?
Tenax Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tenax Therapeutics?
The stock symbol for Tenax Therapeutics is "TENX."
What Is the Tenax Therapeutics Market Cap?
As of today, Tenax Therapeutics market cap is 99.9600M USD.
What Is Tenax Therapeutics's Earnings Per Share (TTM)?
The Tenax Therapeutics EPS (TTM) is -1.4673.
When Is the Next Tenax Therapeutics Earnings Date?
Tenax Therapeutics will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is TENX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tenax Therapeutics Stock Split?
Tenax Therapeutics has split 5 times.
How Many Employees Does Tenax Therapeutics Have?
Tenax Therapeutics has 15 employees.
What is the current trading status of Tenax Therapeutics (TENX)?
As of Aug 21, 2026, Tenax Therapeutics (TENX) is trading at a price of 1.7350 USD, with a previous close of 1.7800 USD. The stock has fluctuated within a day range of 1.7300 USD to 1.8400 USD, while its 52-week range spans from 1.3100 USD to 19.4000 USD.
What Is Tenax Therapeutics (TENX) Price Target According to Analysts?
The average 12-month price target for Tenax Therapeutics is 11.7000 USD, with a high estimate of 36 USD and a low estimate of 4 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +574.35% Upside potential.
What Is the TENX Premarket Price?
TENX's last pre-market stock price is 1.8000 USD. The pre-market share volume is 99,450.0000, and the stock has decreased by 0.0200, or 1.1200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.